BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34396865)

  • 1. Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease.
    Naiem AA; Doonan RJ; Steinmetz OK; MacKenzie KS; Girsowicz E; Bayne JP; Obrand DI; Gill HL
    Vascular; 2022 Oct; 30(5):882-890. PubMed ID: 34396865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
    AbuRahma AF; Beasley M; AbuRahma ZT; Davis M; Adams E; Dean LS; Shapiro J; Scott G; Davis E
    J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
    Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of endovascular therapies for chronic limb-threatening ischemia and claudication.
    Chu D; Zheng X; Mao J; Ramsey L; Mukherjee D
    J Vasc Surg; 2024 Apr; 79(4):875-886.e8. PubMed ID: 38070783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia.
    Naiem AA; Bergeron A; MacKenzie KS; Obrand DI; Steinmetz OK; Bayne JP; Gill HL; Girsowicz E
    J Vasc Surg; 2023 Mar; 77(3):858-863. PubMed ID: 36332807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk Factor Analysis and Long-Term Outcomes in Patients with Endovascular Revascularization for Intermittent Claudication or Chronic Limb-Threatening Ischemia.
    Fung V; Chan YC; Cheung GC; Cheng SW
    Ann Vasc Surg; 2023 Feb; 89():261-268. PubMed ID: 36162626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia.
    Groot Jebbink E; van Wijck I; Holewijn S; Iida O; Spinelli D; Saxon RR; Zeller T; Okhi T; Bosiers M; Reijnen MMPJ
    Catheter Cardiovasc Interv; 2022 Apr; 99(5):1714-1722. PubMed ID: 35253348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women are Not at Higher Risk for Reintervention or Major Amputation after Lower Extremity Atherectomy for Peripheral Artery Disease.
    Israni N; Lee J; Bai H; Storch J; Chen J; Cooke PV; Blanchard O; Kim SY; Tadros RO; Lookstein R; Faries PL; Vouyouka AG
    Ann Vasc Surg; 2023 Sep; 95():95-107. PubMed ID: 37080286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Outcomes of Open Femoropopliteal Bypass by Autogenous Vein Graft in Infra-inguinal Arterial Occlusive Disease.
    Mathlouthi A; Zarrintan S; Khan MA; Malas MB
    Ann Vasc Surg; 2022 Oct; 86():184-189. PubMed ID: 35470046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.
    Mohamedali A; Kiwan G; Kim T; Zhang Y; Zhuo H; Tonnessen B; Dardik A; Chaar CIO
    Ann Vasc Surg; 2022 Feb; 79():56-64. PubMed ID: 34656724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A scoping review of female sex-related outcomes after endovascular intervention for lifestyle-limiting claudication and chronic limb-threatening ischemia.
    Manvar-Singh P; Folk A; Genovese EA
    Semin Vasc Surg; 2023 Dec; 36(4):541-549. PubMed ID: 38030328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long-term outcome after common femoral artery hybrid procedure in patients with intermittent claudication and chronic limb threatening ischemia.
    Woronowicz-Kmiec S; Betz T; Töpel I; Bröckner S; Steinbauer M; Uhl C
    Vasa; 2021 Sep; 50(5):363-371. PubMed ID: 33973817
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease.
    Ramkumar N; Suckow BD; Behrendt CA; Mackenzie TA; Sedrakyan A; Brown JR; Goodney PP
    Catheter Cardiovasc Interv; 2023 Apr; 101(5):877-887. PubMed ID: 36924009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of drug-coated balloon angioplasty in patients with femoropopliteal disease: A real-world single-center experience.
    AbuRahma AF; AbuRahma ZT; Scott G; Adams E; Beasley M; Davis M; Dean LS; Davis E
    J Vasc Surg; 2019 Dec; 70(6):1950-1959. PubMed ID: 31401115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.